227 related articles for article (PubMed ID: 31609494)
1. Risk factors of de novo hepatitis B virus infection in pediatric hepatitis B core antibody positive liver graft recipients under prophylactic therapy.
Dong C; Song Z; Chen J; Ma N; Meng X; Sun C; Duan K; Bi B; Wang K; Qin H; Han C; Yang Y; Zhang F; Zheng W; Gao W
J Gastroenterol Hepatol; 2020 May; 35(5):827-832. PubMed ID: 31609494
[TBL] [Abstract][Full Text] [Related]
2. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Strategy Against De Novo Hepatitis B Virus Infection for Pediatric Recipients Who Receive Hepatitis B Core Antibody-Positive Liver Grafts.
Song Z; Dong C; Meng X; Sun C; Wang K; Qin H; Han C; Yang Y; Zhang F; Zheng W; Chen J; Duan K; Bi B; Gao W
Liver Transpl; 2021 Jan; 27(1):96-105. PubMed ID: 32511854
[TBL] [Abstract][Full Text] [Related]
4. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation.
Rao W; Xie M; Yang T; Zhang JJ; Gao W; Deng YL; Zheng H; Pan C; Liu YH; Shen ZY
World J Gastroenterol; 2014 Sep; 20(36):13159-66. PubMed ID: 25278711
[TBL] [Abstract][Full Text] [Related]
6. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
Chang MS; Olsen SK; Pichardo EM; Stiles JB; Rosenthal-Cogan L; Brubaker WD; Guarrera JV; Emond JC; Brown RS
Transplantation; 2013 Apr; 95(7):960-5. PubMed ID: 23545507
[TBL] [Abstract][Full Text] [Related]
7. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Zhu JJ; Wang SY; Qiu DK
J Dig Dis; 2013 Aug; 14(8):439-45. PubMed ID: 23638710
[TBL] [Abstract][Full Text] [Related]
8. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
9. De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: analysis by determining complete sequence of the genome.
Rokuhara A; Tanaka E; Yagi S; Mizokami M; Hashikura Y; Kawasaki S; Kiyosawa K
J Med Virol; 2000 Dec; 62(4):471-8. PubMed ID: 11074476
[TBL] [Abstract][Full Text] [Related]
10. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.
Lin CC; Chen CL; Concejero A; Wang CC; Wang SH; Liu YW; Yang CH; Yong CC; Lin TS; Jawan B; Cheng YF; Eng HL
Am J Transplant; 2007 Jan; 7(1):195-200. PubMed ID: 17227568
[TBL] [Abstract][Full Text] [Related]
11. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
[TBL] [Abstract][Full Text] [Related]
12. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
Chen YS; Wang CC; de Villa VH; Wang SH; Cheng YF; Huang TL; Jawan B; Chiu KW; Chen CL
Clin Transplant; 2002 Dec; 16(6):405-9. PubMed ID: 12437618
[TBL] [Abstract][Full Text] [Related]
13. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
Dong C; Gao W; Ma N; Sun C; Zheng WP; Wang K; Shen ZY
Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27933716
[TBL] [Abstract][Full Text] [Related]
14. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
[TBL] [Abstract][Full Text] [Related]
15. De Novo Hepatitis B Infection From Hepatitis B Core Antibody-Positive Donors During Hepatitis B Immunoglobulin Prophylaxis.
Shin M; Chang SH
Exp Clin Transplant; 2016 Feb; 14(1):106-8. PubMed ID: 26325029
[TBL] [Abstract][Full Text] [Related]
16. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
[TBL] [Abstract][Full Text] [Related]
17. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
[TBL] [Abstract][Full Text] [Related]
18. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
Skagen CL; Jou JH; Said A
Clin Transplant; 2011; 25(3):E243-9. PubMed ID: 21323735
[TBL] [Abstract][Full Text] [Related]
19. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
[TBL] [Abstract][Full Text] [Related]
20. De novo and apparent de novo hepatitis B virus infection after liver transplantation.
Roche B; Samuel D; Gigou M; Feray C; Virot V; Schmets L; David MF; Arulnaden JL; Bismuth A; Reynes M; Bismuth H
J Hepatol; 1997 Mar; 26(3):517-26. PubMed ID: 9075658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]